首页> 外文OA文献 >Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y(2) and P2Y(6) receptors on cardiomyocytes and release of UTP in man during myocardial infarction
【2h】

Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y(2) and P2Y(6) receptors on cardiomyocytes and release of UTP in man during myocardial infarction

机译:三磷酸尿苷(UTp)和二磷酸尿苷(UDp)通过p2Y(2)和p2Y(6)受体对心肌细胞的正性肌力作用和心肌梗死时人体内UTp的释放

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to examine a possible role for extracellular pyrimidines as inotropic factors for the heart. First, nucleotide plasma levels were measured to evaluate whether UTP is released in patients with coronary heart disease. Then, inotropic effects of pyrimidines were examined in isolated mouse cardiomyocytes. Finally, expression of pyrimidine-selective receptors ( a subgroup of the P2 receptors) was studied in human and mouse heart, using real time polymerase chain reaction, Western blot, and immunohistochemistry. Venous plasma levels of UTP were increased (57%) in patients with myocardial infarction. In electrically stimulated cardiomyocytes the stable P2Y(2/4) agonist UTP gamma S increased contraction by 52%, similar to beta(1)-adrenergic stimulation with isoproterenol (65%). The P2Y(6)-agonist UDP gamma S also increased cardiomyocyte contraction (35%), an effect abolished by the P2Y(6)-blocker MRS2578. The phospholipase C inhibitor U73122 inhibited both the UDP beta S and the UTP gamma S-induced inotropic effect, indicating an IP3-mediated effect via P2Y(6) receptors. The P2Y(14) agonist UDP-glucose was without effect. Quantification of mRNA with real time polymerase chain reaction revealed P2Y(2) as the most abundant pyrimidine receptor expressed in cardiomyocytes from man. Presence of P2Y(6) receptor mRNA was detected in both species and confirmed at protein level with Western blot and immunohistochemistry in man. In conclusion, UTP levels are increased in humans during myocardial infarction, giving the first evidence for UTP release in man. UTP is a cardiac inotropic factor most likely by activation of P2Y(2) receptors in man. For the first time we demonstrate inotropic effects of UDP, mediated by P2Y(6) receptors via an IP3-dependent pathway. Thus, the extracellular pyrimidines ( UTP and UDP) could be important inotropic factors involved in the development of cardiac disease.
机译:这项研究的目的是研究细胞外嘧啶作为心脏的正性肌力因子的可能作用。首先,测量核苷酸血浆水平以评估冠心病患者是否释放了UTP。然后,在分离的小鼠心肌细胞中检查嘧啶的肌力作用。最后,使用实时聚合酶链反应,蛋白质印迹和免疫组化研究了嘧啶选择性受体(P2受体的一个子集)在人和小鼠心脏中的表达。心肌梗死患者的血浆血浆UTP水平升高(57%)。在电刺激的心肌细胞中,稳定的P2Y(2/4)激动剂UTPγS使收缩增加52%,类似于用异丙肾上腺素(65%)的β(1)-肾上腺素能刺激。 P2Y(6)-激动剂UDPγS也增加了心肌细胞收缩(35%),P2Y(6)-阻滞剂MRS2578取消了这种作用。磷脂酶C抑制剂U73122抑制UDP beta S和UTPγS诱导的变力作用,表明通过P2Y(6)受体的IP3介导的作用。 P2Y(14)激动剂UDP-葡萄糖无效。实时聚合酶链反应的mRNA定量显示P2Y(2)是人类心肌细胞中表达的最丰富的嘧啶受体。在两个物种中均检测到P2Y(6)受体mRNA的存在,并通过蛋白质印迹和免疫组化技术在人中证实了其蛋白水平。总之,在心肌梗塞期间,人的UTP水平升高,这为人UTP释放提供了第一个证据。 UTP是最有可能通过激活人类中的P2Y(2)受体而引起的心脏收缩力因子。第一次我们证明UDP的正性肌力作用,通过IP3依赖性途径由P2Y(6)受体介导。因此,细胞外嘧啶(UTP和UDP)可能是参与心脏病发展的重要正性肌力因子。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号